Adverse Experience Data. The Parties shall be responsible for reporting and investigating Adverse Experience Data in accordance with a separate safety data exchange protocol to be mutually agreed by SPI and Takeda.
Appears in 3 contracts
Sources: Supply and Purchase Agreement, Supply and Purchase Agreement (Sucampo Pharmaceuticals, Inc.), Supply and Purchase Agreement (Sucampo Pharmaceuticals, Inc.)